Drug design, development and therapy

Epidemiologic surveillance

Epidemiological surveillance of highly pathogenic agents is limited worldwide, especially because of several key factors, such as limited financial resources, lacking of specialized infrastructure, high level federal and state policy discussions, lacking of high quality technical capacities to enable good management, planning, and supervision among the different agencies involved, and others.

The 2014-2016 Ebola outbreak in Africa and 2013 Cholera outbreak in Mexico are illustrative scenarios of the national and international threats we can be exposed to. A rapid biological response to prevent and minimize the risk for infection, propagation, and harm to the population should be a national and international priority. CeBGID combines the expertise of medical, nursing and veterinary professionals to complete syndromic surveillance in western Mexico, especially in rural areas where the diagnostic capacity and medical specialized infrastructure are limited.

CeBGID conducts epidemiological research for agents of importance in global public health, combining the design and development of novel detection methods that allow a rapid identification.